An international research team has developed an optical technique capable of measuring a material's chemical composition, molecular structure, and mechanical properties simultaneously, from a single point, without touching or labeling the sample. The work, published in Nature Communications, was led by Specto Photonics, a Milan-based deep-tech company, working with Politecnico di Milano and academic partners in Italy, Denmark, and Australia. For lab managers overseeing pharmaceutical analysis, the approach targets a persistent bottleneck: characterizing a drug's solid-state form typically requires several separate instruments and multiple measurements.
Editor's Note: Pharmaceutical labs have spent decades stitching together separate instruments, XRD for crystal structure, Raman for chemical ID, DSC for thermal behavior, to build a full picture of a drug's solid-state form. A new multimodal optical technique from an Italian deep-tech startup collapses several of those measurements into one, which raises real questions for lab managers about where it might fit alongside, or eventually replace, existing analytical workflows.
What the multimodal spectroscopy platform actually measures
The method works by capturing the full vibrational spectrum, the complete range of ways light scatters off a material's molecular vibrations. Three distinct signals live within that spectrum, each requiring different detection strategies to isolate.
- Brillouin scattering reveals mechanical properties such as stiffness and viscosity
- Ultra-low-frequency Raman (ULFR) reveals molecular structure and organization
- Conventional Raman reveals chemical composition
The technical obstacle has always been that the faintest of these signals, the mechanical and structural ones, sit buried under intense scattered laser light. Specto's proprietary Birefringence-Induced Phase Delay (BIPD) filter suppresses that background well enough to record all three signals from the same illumination spot. Dr. Giuseppe Antonacci, the project's coordinator and Specto's CEO, described the appeal of the combined dataset: "This approach reveals the significance of the combined information from different modalities which access the stiffness, molecular orientation and the chemical composition of the material by only shining laser light."
Why solid-state characterization is a recurring pain point in drug development
A drug's solid-state form, whether crystalline or amorphous, and how it was processed, directly shapes its solubility, stability, shelf life, and bioavailability. Amorphous formulations are increasingly common because they can improve solubility for poorly water-soluble drugs, yet they remain notoriously hard to characterize with conventional tools. A peer-reviewed review in the AAPS Journal notes that these formulations can achieve supersaturated concentrations, which complicates both solubility measurement and quality control method development.
The research team tested their platform on common active pharmaceutical ingredients, including indomethacin, ibuprofen, and paracetamol. Notably, it distinguished between amorphous indomethacin samples produced by different manufacturing routes, melt-quenching versus ball-milling, a distinction the paper says was hard to resolve using Raman-based methods alone. The Brillouin signal alone showed a statistically significant difference between the two amorphous forms, while the chemical and structural signals showed only minimal variation.
The team also mapped the mechanical, structural, and chemical makeup across an intact ibuprofen tablet, an extension from single-point spectroscopy into spatial imaging. This kind of solid-state scrutiny sits alongside other characterization approaches already in use in QA/QC labs, including X-ray diffraction for polymorph screening and inline rheology monitoring for viscoelastic quality attributes, both of which currently require dedicated, single-purpose instruments.
How this fits into the multimodal spectroscopy trend
Combining Brillouin and Raman signals is not itself new; researchers have paired them in biomedical contexts before, including cartilage and cancer cell analysis. What is new here is achieving all three signal types, mechanical, structural, and chemical, from the same measurement spot using an all-optical, contact-free filter design. That distinction matters in a market where portable and compact Raman systems have already been pushing spectroscopic analysis toward faster, more accessible formats.
Lab Quality Management Certificate
The Lab Quality Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
The table below summarizes what each signal contributes on its own, since that context is easy to lose once the three are combined into a single measurement.
| Signal type | Property revealed | Typical standalone use |
|---|---|---|
| Brillouin scattering | Mechanical stiffness and viscosity | Cell mechanics, corneal biomechanics research |
| Ultra-low-frequency Raman | Molecular structure and organization | Polymorph and crystallinity screening |
| Conventional Raman | Chemical composition | API identification, quality control |
Specto Photonics, founded in 2019 and previously focused on miniaturized Brillouin spectrometers for mechanobiology research, is a small company, with roughly eight employees and a single seed funding round to date. That scale is worth keeping in perspective: this result demonstrates scientific feasibility in a research setting, not a commercially available instrument ready for routine QC deployment.
What this means for pharmaceutical quality control labs
The authors describe this as a step toward instruments that could eventually combine three-dimensional views of a material's mechanical, structural, and chemical makeup at sub-micron resolution. For lab managers, the near-term relevance is conceptual rather than immediately operational: a single, label-free measurement capturing all three properties at once could, if commercialized, support formulation design, stability testing, and real-time quality control with less sample waste.
The researchers also point to applications beyond pharmaceuticals, including studying the mechanics of structures inside living cells and characterizing materials where chemical, structural, and mechanical states currently have to be assessed one property at a time. Whether or how quickly this translates into a deployable instrument for pharmaceutical QA/QC labs remains to be seen. Lab managers evaluating multimodal spectroscopy vendors should watch for peer-reviewed validation data and instrument specifications as this technology, and its competitors, mature.
